தொடர்ந்தது மரணதண்டனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தொடர்ந்தது மரணதண்டனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தொடர்ந்தது மரணதண்டனை Today - Breaking & Trending Today

Surna Reports Second Quarter 2021 Results

Surna Reports Second Quarter 2021 Results
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , Tony Mcdonald , Exchange Commission , Surna Inc , Marketing Communications , Net Revenue Increases , Adjusted Net Income Increases , Year Over Driven , Continued Execution , Organic Growth , Surna Cultivation Technologies , Months Ended June , Adjusted Net Income , Cash Add Backs , Non Cash Add Backs , Net Income , Sales Contract , Backlog Information , Surna Cultivation , Consolidated Statements , Three Months Ended June , Six Months Ended June , Cash Flows , Flows From Operating Activities , ஒன்றுபட்டது மாநிலங்களில் , டோனி மக்டொநல்ட் ,

Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results

Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results
Licensing Partners Leveraging PolyXen® Platform Technology Continue To Make Clinical, Regulatory and Commercial Advancement
FRAMINGHAM, MA / ACCESSWIRE /
May 12, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ( Xenetic or the Company ), a biopharmaceutical company focused on advancing XCART, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today reported its financial results for the first quarter of 2021 and provided a corporate update.
During the first quarter our focus remained on advancing the development of our XCART platform, which we believe has the potential to provide a personalized CAR T therapy targeting cancers with a patient-and tumor-specific approach. The commencement of our exploratory patient biopsy trial is a key component of our preclinical development strategy and an important step forward toward advancing into a Phas ....

United States , Jenene Thomas , Jeffrey Eisenberg , Xenetic Biosciences , Platform Technology Continue To Make Clinical , Xenetic Biosciences Inc , Tm Platform Technology Overview , Platform Technology , Company Commissioned Market , Scripps Research , Takeda Pharmaceuticals Co , Continued Execution , Xcart Development Plan With Commencement , Company To Conduct Ind Enabling Studies , Partners Leveraging Polyxen , Chief Executive Officer , Technology Overview , Eastern Europe , B Cell Non Hodgkin , License Agreement , Takeda Pharmaceuticals , Financial Results , First Quarter , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்ரி ஐசன்பெர்க் ,

Extended Stay America Files Preliminary Proxy Statement and Reiterates Board and Management Support for Acquisition Agreement With Blackstone and Starwood Capital

Extended Stay America Files Preliminary Proxy Statement and Reiterates Board and Management Support for Acquisition Agreement With Blackstone and Starwood Capital
Extended Stay America, Inc.
Transaction Provides Immediate, Certain and Compelling Value to Shareholders
Represents Superior Value to the Continued Execution of Extended Stay’s Strategic Plan on a Time and Risk-Adjusted Basis
Marks Culmination of Thorough Actions to Explore Value-Enhancing Alternatives
CHARLOTTE, N.C., April 13, 2021 (GLOBE NEWSWIRE) Extended Stay America, Inc. (“ESA”) and its paired-share REIT, ESH Hospitality, Inc. (“ESH” and, together with ESA, “Extended Stay” or the “Company”) (NASDAQ: STAY) today filed their preliminary joint proxy statement in connection with the Company’s previously announced definitive agreement to be acquired by a 50/50 joint venture between funds managed by Blackstone Real Estate Partners (“Blackstone”) and Starwood Capital G ....

United States , Doug Geoga , Bruce Haase , Starwood Capital Group , Stay America Inc , Boards Of Directors The Company , Hospitality Inc , Franchise Program Time Frame , Transaction Provides Immediate , Compelling Value , Superior Value , Continued Execution , Extended Stay , Strategic Plan , Thorough Actions , Explore Value Enhancing , Stay America , Blackstone Real Estate Partners , Chief Executive Officer , Starwood Capital , Capital Needs , Growth Pressures , Asset Dispositions , Program Time Frame , Nasdaq Stay , Extended Stay America ,

Australis Provides Acquisition and Corporate Update

Australis Provides Acquisition and Corporate Update
News provided by
Share this article
Clearview Capital Consult Appointed for IR
LAS VEGAS, Feb. 9, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ( AUSA or the Company ) today announced that the Company is progressing well towards completion of the previously announced proposed acquisitions of ALPS and Green Therapeutics LLC ( GT ).
Acquisitions Update
The Company is working towards the completion of the acquisition of a 51% interest in ALPS and the acquisition of 100% of the outstanding membership interest in Green Therapeutics, which includes the discontinuation of all previous litigation with Green Therapeutics. As per the Company s commitment to keep our shareholders fully informed and apprised, we are expecting to enter into definitive agreements with ALPS in short order. ....

United States , City Of , United Kingdom , Clark County , Marc Lakmaaker , Thomas Larssen , Duke Fu , Aurora Cannabis Inc , Company Cultivars , Australis Capital Inc , Clark County Department Of Business Licensing , Green Therapeutics , Cann Group , Further Innovation , Capital Consult Appointed , Hawks Haze , Missouri State , Cannabis Control Board , Clark County Department , Continued Execution , Record Level Revenues , Mind Inc , Clearview Capital Consult , Equality Green , Folium Biosciences , ஒன்றுபட்டது மாநிலங்களில் ,